Researchers at the Weill Institute for Cell and Molecular Biology have uncovered new evidence that two major types of gene-controlling DNA sequences, promoters and enhancers, operate with a shared ...
Most people alive today carry fragments of Neanderthal DNA in their genome. Now scientists are gaining a more intimate ...
For years, studies have analysed huge numbers of people - including so-called 'super-agers' who live remarkably long and healthy lives - to examine the factors that influence ageing.
Choosing A-Levels can feel stressful for both students and parents. Some subjects are known to be harder because they need strong maths skills, long essays, or complex problem-solving. Many families ...
Convicted sex offender Jeffrey Epstein paid for genetic testing in an apparent bid to harness his own genetic material for regenerative medicine – which is aimed at repairing the body by developing ...
Professor Jared Parrish spoke to BYU students on Jan. 15 about applying artificial intelligence and data science to maternal and child health. Parrish, a BYU alumnus turned maternal health ...
Wave Life Sciences has the fate of its lead RNA editing candidate back in its own hands. Partner GSK has decided not to take over development of WVE-006, an experimental oligonucleotide for alpha-1 ...
After two years of layoffs and funding pullbacks, South San Francisco’s life science industry is showing stronger signs of a comeback— though more mega-rounds and less early-stage funding could ...
A new study reveals that super agers over 80 have a distinct genetic edge. They are much less likely to carry the gene most associated with Alzheimer’s risk, even when compared with other healthy ...
El Monte-based technology company Fulgent Genetics Inc. agreed to acquire selected assets of Bako Diagnostics, a pathology laboratory based in Alpharetta, GA, and to acquire StrataDx, a ...
After holding its breath for several rough years, Greater Boston’s life sciences sector is cautiously coming up for air. It was a year of devastating uncertainty for the sector and its roughly 75,000 ...
Over the past four years, private equity (PE) firms that invested in life science assets have faced a difficult reality. While many investors still debate whether some sectors of the market are in a ...